Mast Cell CD30 Ligand is Upregulated in Cutaneous Inflammation and Mediates Degranulation-independent Chemokine Secretion

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2006 Sep 12

PMID 16964309

Citations 40

Authors

Marie Fischer

Ilkka T Harvima

Ricardo F S Carvalho

Christine Moller

Anita Naukkarinen

Gunilla Enblad

Gunnar Nilsson

Affiliations

Soon will be listed here.

Abstract

Mast cells are involved in many disorders where the triggering mechanism that leads to degranulation and/or cytokine secretion has not been defined. Several chronic inflammatory diseases are associated with increased mast cell numbers and upregulation of the TNF receptor family member CD30, but the role of elevated CD30 expression is poorly understood. Here we report what we believe to be a novel way to activate mast cells with CD30 that leads to degranulation-independent secretion of chemokines. CD30 induced a de novo synthesis and secretion of the chemokines IL-8, macrophage inflammatory protein-1alpha (MIP-1alpha), and MIP-1beta, a process involving the MAPK/ERK pathway. Mast cells were found to be the predominant CD30 ligand-positive (CD30L-positive) cell in the chronic inflammatory skin diseases psoriasis and atopic dermatitis, and both CD30 and CD30L expression were upregulated in lesional skin in these conditions. Furthermore, the number of IL-8-positive mast cells was elevated both in psoriatic and atopic dermatitis lesional skin as well as in ex vivo CD30-treated healthy skin organ cultures. In summary, characterization of CD30 activation of mast cells has uncovered an IgE-independent pathway that is of importance in understanding the entirety of the role of mast cells in diseases associated with mast cells and CD30 expression. These diseases include Hodgkin lymphoma, atopic dermatitis, and psoriasis.

Citing Articles

Can Serum Fetuin-A be Used as a Marker for Cardiovascular Involvement in Psoriatic Patients?.

Saleh H, Sheha A, Eskander N, Elhawatky A, Hassen S J Psoriasis Psoriatic Arthritis. 2024; 8(2):66-73.

PMID: 39296671 PMC: 11361489. DOI: 10.1177/24755303221135570.

Multicenter proteome-wide Mendelian randomization study identifies causal plasma proteins in melanoma and non-melanoma skin cancers.

Li Y, Li Q, Cao Z, Wu J Commun Biol. 2024; 7(1):857.

PMID: 39003418 PMC: 11246481. DOI: 10.1038/s42003-024-06538-2.

Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas.

Li Z, Guo W, Bai O Front Oncol. 2024; 13:1301437.

PMID: 38188299 PMC: 10767573. DOI: 10.3389/fonc.2023.1301437.

T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis.

Zheng C, Shi Y, Zou Y Front Immunol. 2023; 14:1081999.

PMID: 36993982 PMC: 10040887. DOI: 10.3389/fimmu.2023.1081999.

-Infected Sand Fly Bites Enhance Mast Cell Degranulation.

Sanchez-Garcia L, Perez-Torres A, Gudino-Zayas M, Zamora-Chimal J, Meneses C, Kamhawi S Pathogens. 2023; 12(2).

PMID: 36839479 PMC: 9960273. DOI: 10.3390/pathogens12020207.

References

Caproni M, Bianchi B, DElios M, De Carli M, Amedei A, Fabbri P . In vivo relevance of CD30 in atopic dermatitis. Allergy. 1997; 52(11):1063-70. DOI: 10.1111/j.1398-9995.1997.tb00177.x. View

Suzuki I, Fink P . Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J Exp Med. 1998; 187(1):123-8. PMC: 2199194. DOI: 10.1084/jem.187.1.123. View

Ackermann L, Harvima I . Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch Dermatol Res. 1998; 290(7):353-9. DOI: 10.1007/s004030050317. View

Horie R, Watanabe T . CD30: expression and function in health and disease. Semin Immunol. 1998; 10(6):457-70. DOI: 10.1006/smim.1998.0156. View

Galli S, Maurer M, Lantz C . Mast cells as sentinels of innate immunity. Curr Opin Immunol. 1999; 11(1):53-9. DOI: 10.1016/s0952-7915(99)80010-7. View

Ackermann L, Harvima I, Pelkonen J, Naukkarinen A, Harvima R, Horsmanheimo M . Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol. 1999; 140(4):624-33. DOI: 10.1046/j.1365-2133.1999.02760.x. View

Hatano Y, Katagiri K, Takayasu S . Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD). Clin Exp Immunol. 1999; 117(2):237-43. PMC: 1905337. DOI: 10.1046/j.1365-2249.1999.00982.x. View

Galli S, Nakae S, Tsai M . Mast cells in the development of adaptive immune responses. Nat Immunol. 2005; 6(2):135-42. DOI: 10.1038/ni1158. View

Salamon P, Shoham N, Gavrieli R, Wolach B, Mekori Y . Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy. 2005; 60(10):1316-9. DOI: 10.1111/j.1398-9995.2005.00886.x. View

10.

Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

11.

Ferenczi K, Burack L, Pope M, Krueger J, Austin L . CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry. J Autoimmun. 2000; 14(1):63-78. DOI: 10.1006/jaut.1999.0343. View

12.

Secor V, Secor W, Gutekunst C, Brown M . Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med. 2000; 191(5):813-22. PMC: 2195850. DOI: 10.1084/jem.191.5.813. View

13.

Cerutti A, Schaffer A, Goodwin R, Shah S, Zan H, Ely S . Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. J Immunol. 2000; 165(2):786-94. PMC: 4621014. DOI: 10.4049/jimmunol.165.2.786. View

14.

Coussens L, Werb Z . Inflammatory cells and cancer: think different!. J Exp Med. 2001; 193(6):F23-6. PMC: 2193419. DOI: 10.1084/jem.193.6.f23. View

15.

Duan H, Koga T, Kohda F, Hara H, Urabe K, Furue M . Interleukin-8-positive neutrophils in psoriasis. J Dermatol Sci. 2001; 26(2):119-24. DOI: 10.1016/s0923-1811(00)00167-5. View

16.

Higashi N, Bang K, Gesser B, Lund M, Thestrup-Pedersen K . Cytokine expression of skin T-lymphocytes from patients with atopic dermatitis. Acta Derm Venereol. 2001; 81(1):3-7. DOI: 10.1080/00015550117325. View

17.

Molin D, Fischer M, Xiang Z, Larsson U, Harvima I, Venge P . Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease. Br J Haematol. 2001; 114(3):616-23. DOI: 10.1046/j.1365-2141.2001.02977.x. View

18.

Jiang W, Chattedee A, Raychaudhuri S, Raychaudhuri S, Farber E . Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int J Dermatol. 2001; 40(11):699-703. DOI: 10.1046/j.1365-4362.2001.01262.x. View

19.

Mellor E, Austen K, Boyce J . Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med. 2002; 195(5):583-92. PMC: 2193768. DOI: 10.1084/jem.20020044. View

20.

Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, Ra C . Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest. 2002; 109(10):1351-9. PMC: 150977. DOI: 10.1172/JCI14704. View